Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Health Care Savings: The Economic Value of Diagnostic and Therapeutic Care for Obstructive Sleep Apnea.

Literature DB >> 27448424

Health Care Savings: The Economic Value of Diagnostic and Therapeutic Care for Obstructive Sleep Apnea.

Abstract

ABSTRACT: Two new white papers commissioned by the American Academy of Sleep Medicine (AASM) provide an in-depth, detailed analysis of the vast economic burden associated with undiagnosed and untreated obstructive sleep apnea among adults in the United States. While the individual health benefits of treating OSA are well established, these papers emphasize the value of comprehensive OSA testing and treatment, which can provide dramatic health care savings for payors and large employers.

Entities: Disease

Mesh：

Year: 2016 PMID： 27448424 PMCID： PMC4957182 DOI： 10.5664/jcsm.6034

Source DB: PubMed Journal: J Clin Sleep Med ISSN： 1550-9389 Impact factor: 4.062

10 in total

1. Cost justification for diagnosis and treatment of obstructive sleep apnea. Position statement of the American Academy of Sleep Medicine.

Authors:
Journal: Sleep Date: 2000-12-15 Impact factor: 5.849

2. Cost-effectiveness of split-night polysomnography and home studies in the evaluation of obstructive sleep apnea syndrome.

Authors: Peter A Deutsch; Michael S Simmons; Jeanne M Wallace
Journal: J Clin Sleep Med Date: 2006-04-15 Impact factor: 4.062

3. The Triple Aim. Optimizing health, care and cost.

Authors:
Journal: Healthc Exec Date: 2009 Jan-Feb

4. Obstructive sleep apnea and health benefits purchasing: an employer perspective.

Authors: Bruce Sherman
Journal: J Clin Sleep Med Date: 2013-03-15 Impact factor: 4.062

5. Cost-effectiveness of continuous positive airway pressure therapy for moderate to severe obstructive sleep apnea/hypopnea.

Authors: Najib T Ayas; J Mark FitzGerald; John A Fleetham; David P White; Michael Schulzer; C Frank Ryan; Reza Ghaeli; G William Mercer; Peter Cooper; Michael C Y Tan; Carlo A Marra
Journal: Arch Intern Med Date: 2006-05-08

6. A Unified Plan to Strengthen the Sleep Medicine Pipeline and Maximize Our Workforce.

Authors: Nathaniel F Watson
Journal: J Clin Sleep Med Date: 2016-06-15 Impact factor: 4.062

7. An integrated health-economic analysis of diagnostic and therapeutic strategies in the treatment of moderate-to-severe obstructive sleep apnea.

Authors: Jan B Pietzsch; Abigail Garner; Lauren E Cipriano; John H Linehan
Journal: Sleep Date: 2011-06-01 Impact factor: 5.849

8. Increased prevalence of sleep-disordered breathing in adults.

Authors: Paul E Peppard; Terry Young; Jodi H Barnet; Mari Palta; Erika W Hagen; Khin Mae Hla
Journal: Am J Epidemiol Date: 2013-04-14 Impact factor: 4.897

9. The occurrence of sleep-disordered breathing among middle-aged adults.

Authors: T Young; M Palta; J Dempsey; J Skatrud; S Weber; S Badr
Journal: N Engl J Med Date: 1993-04-29 Impact factor: 91.245

Review 10. Increased physician-reported sleep apnea: the National Ambulatory Medical Care Survey.

Authors: Andrew M Namen; Donnie P Dunagan; Alan Fleischer; Janine Tillett; Molly Barnett; W Vaughn McCall; Edward F Haponik
Journal: Chest Date: 2002-06 Impact factor: 9.410

10 in total

31 in total

Review 1. Estimation of the global prevalence and burden of obstructive sleep apnoea: a literature-based analysis.

Authors: Adam V Benjafield; Najib T Ayas; Peter R Eastwood; Raphael Heinzer; Mary S M Ip; Mary J Morrell; Carlos M Nunez; Sanjay R Patel; Thomas Penzel; Jean-Louis Pépin; Paul E Peppard; Sanjeev Sinha; Sergio Tufik; Kate Valentine; Atul Malhotra
Journal: Lancet Respir Med Date: 2019-07-09 Impact factor: 30.700

Health Care Savings: The Economic Value of Diagnostic and Therapeutic Care for Obstructive Sleep Apnea.

1. Cost justification for diagnosis and treatment of obstructive sleep apnea. Position statement of the American Academy of Sleep Medicine.

2. Cost-effectiveness of split-night polysomnography and home studies in the evaluation of obstructive sleep apnea syndrome.

3. The Triple Aim. Optimizing health, care and cost.

4. Obstructive sleep apnea and health benefits purchasing: an employer perspective.

5. Cost-effectiveness of continuous positive airway pressure therapy for moderate to severe obstructive sleep apnea/hypopnea.

6. A Unified Plan to Strengthen the Sleep Medicine Pipeline and Maximize Our Workforce.

7. An integrated health-economic analysis of diagnostic and therapeutic strategies in the treatment of moderate-to-severe obstructive sleep apnea.

8. Increased prevalence of sleep-disordered breathing in adults.

9. The occurrence of sleep-disordered breathing among middle-aged adults.

Review 10. Increased physician-reported sleep apnea: the National Ambulatory Medical Care Survey.

Review 1. Estimation of the global prevalence and burden of obstructive sleep apnoea: a literature-based analysis.

Review 2. Obstructive Sleep Apnea and the Brain: a Focus on Gray and White Matter Structure.

3. Validation of NoSAS score for screening of sleep-disordered breathing in a multiethnic Asian population.

4. Obstructive Sleep Apnea Diagnosis and Management.

5. Value-Based Sleep in the Workplace.

6. Short-term CPAP adherence in obstructive sleep apnea: a big data analysis using real world data.

7. Evaluating the performance of five scoring systems for prescreening obstructive sleep apnea-hypopnea syndrome.

8. Prevalence and Sources of Errors in Positive Airway Pressure Therapy Provisioning.

9. Impact of Arterial Stiffness on WatchPAT Variables in Patients With Obstructive Sleep Apnea.

10. Recognition and Diagnosis of Obstructive Sleep Apnea in Older Americans.